EFLM novinky
9. 5. 2026
- EFLM position statement on the proposed 2025/0404(COD) IVDR Amendment of Article 5.5
- Methodology and quality assurance practices in performing anti-extractable nuclear antigen (ENA) analysis: an EFLM report on an international survey
- EFLM supports the proposed reform of Art 5.5 in the IVDR to protect the continued use of in-house developed tests in medical labs. These are essential when commercial alternatives are unavailable.
- A revised GSL checklist is now available, updated by the EFLM Green and Sustainable Laboratories Committee to better reflect real-world clinical lab practices and incorporate feedback from certified
- The PDFs of all presentations from the 2026 EFLM Strategic Conference are online